TECHNETIUM Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Technetium, and when can generic versions of Technetium launch?
Technetium is a drug marketed by Ge Healthcare, Jubilant Draximage, Cardinal Health 414, Curium, Sun Pharm Inds Inc, Mallinckrodt, Jubilant, and Medi-radiopharma. and is included in seventeen NDAs.
The generic ingredient in TECHNETIUM is technetium tc-99m pentetate kit. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the technetium tc-99m pentetate kit profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Technetium
A generic version of TECHNETIUM was approved as technetium tc-99m pentetate kit by CURIUM on March 26th, 2025.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for TECHNETIUM?
- What are the global sales for TECHNETIUM?
- What is Average Wholesale Price for TECHNETIUM?
Summary for TECHNETIUM
| US Patents: | 0 |
| Applicants: | 8 |
| NDAs: | 17 |
| DailyMed Link: | TECHNETIUM at DailyMed |

